U.S. Personal Products Stock News

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...

Macy’s recently saw a surge in bearish options activity and rising caution tied to insider selling and an upcoming earnings report expected on March 5, adding pressure to sentiment around the retailer’s outlook. This comes as Macy’s continues to refresh its assortment and elevate its brand portfolio, including adding more luxury labels under its current leadership team. Next, we’ll examine how this spike in bearish options positioning ahead of earnings could influence Macy’s longer-term...

If you are wondering whether monday.com is starting to look attractive after a rough stretch, this article will walk through what its current share price might be implying about underlying value. The stock last closed at US$70.13, and has seen a 3.1% decline over 7 days, a 45.8% decline over 30 days, and a 51.1% decline year to date, with a 76.5% decline over the past year and a 55.5% decline over three years. These sharp moves have kept monday.com on many investors' watchlists, as large...

ON Semiconductor (ON) has caught investor attention after management pointed to an inflection in its business, with sequential momentum in automotive, industrial, and AI data centers supported by silicon carbide and gallium nitride products. See our latest analysis for ON Semiconductor. ON Semiconductor’s share price has climbed 12.08% over the past month and 43.80% over the last 90 days, while the 1 year total shareholder return of 30.09% and 5 year total shareholder return of 64.35% point...

Context for Sprinklr’s recent share performance Sprinklr (CXM) has seen its share price under pressure, with returns of about a 7% decline over the past week, a 23% decline over the past month, and a 28% decline over the past 3 months. See our latest analysis for Sprinklr. The recent selloff has been broad based for Sprinklr, with a 1-year total shareholder return of about 40% decline and a 3-year total shareholder return of roughly 53% decline, pointing to fading momentum despite its AI...

Recent figures around ArcBest (ARCB) are drawing attention, with sluggish unit growth, softer return on invested capital, and a modest 2.8% EPS compound growth rate over five years raising fresh questions about its earnings quality. See our latest analysis for ArcBest. ArcBest’s recent 5.8% one day share price decline and 5.2% seven day pullback come after a strong 90 day share price return of 54.1% and a five year total shareholder return of 61.8%. This may hint that momentum is cooling...

LKQ is overhauling its business, including selling its self service segment and reviewing a range of potential business alternatives. The company has also approved a restructuring plan aimed at improving operational efficiency. These moves come as LKQ faces macroeconomic and tariff pressures alongside softer demand conditions. LKQ, traded as NasdaqGS:LKQ, is making these changes with its shares around $33.29. The stock is up 10.9% year to date, but has seen a 16.5% decline over the past...

Village Farms International, Inc. recently amended its Canadian cannabis credit facility, increasing loan commitments by C$15 million and extending maturities to February 2029, with an initial C$5 million drawn at variable rates currently below 6.0%. This move adds low-cost, delayed-draw debt capacity that can support cannabis expansion and acquisitions while keeping existing facility terms intact. Next, we will examine how this expanded, longer-dated cannabis credit facility may influence...

The U.S. Supreme Court’s decision to overturn Trump era tariffs has quickly filtered into markets. Under Armour (UAA) is among the stocks reacting as investors reassess potential cost pressures for manufacturers and retailers. See our latest analysis for Under Armour. Against the tariff news, Under Armour’s recent 30 day share price return of 20% and 90 day return of 69.33% point to building momentum. However, the 5 year total shareholder return of a 66.49% decline shows the longer term...

Seacoast Banking Corporation of Florida (SBCF) has drawn investor attention after recent share price moves. The stock has shown mixed short-term performance, while longer-term returns and current profit figures invite a closer look. See our latest analysis for Seacoast Banking Corporation of Florida. The recent 1-day share price return of a 4.77% decline at a last close of US$32.14 follows softer 7-day and 30-day share price returns. However, the 1-year total shareholder return of 18.17% and...

Disc Medicine announced that the FDA issued a Complete Response Letter for its accelerated approval filing of bitopertin in erythropoietic protoporphyria, citing insufficient evidence that reductions in metal-free PPIX translate into improved sunlight tolerance despite positive biomarker data from the AURORA and BEACON trials. An interesting element for investors is that the FDA explicitly pointed to the ongoing APOLLO Phase III study as a potential path to traditional approval, while Disc...

Wondering if Equity LifeStyle Properties at around US$67.96 is offering fair value right now, or if the price is running ahead of reality? The stock has returned 0.2% over the past week, 6.2% over the last month, 13.7% year to date, 4.8% over 1 year, 8.0% over 3 years and 26.3% over 5 years. This provides a mix of short and longer term outcomes to weigh up. Recent news coverage has focused on Equity LifeStyle Properties as a large US listed real estate owner and operator, with investors...

Axsome Therapeutics (AXSM) closed FY 2025 with Q4 revenue of US$196.0 million and a basic EPS loss of US$0.56, alongside a net income loss of US$28.6 million, keeping profitability firmly in focus for investors. The company has seen quarterly revenue move from US$118.8 million in Q4 2024 to US$196.0 million in Q4 2025, while basic EPS has shifted from a loss of US$1.54 to a loss of US$0.56 over the same period. This frames a story where top line scale is running ahead of bottom line progress...

Enpro Inc. reported past fourth-quarter 2025 sales of US$295.4 million and a net loss of US$32 million, issued 2026 revenue growth guidance of 8% to 12%, and signaled ongoing capacity for acquisitions under its Enpro 3.0 framework. The company is pairing a small quarterly dividend increase to US$0.32 per share with plans to pursue acquisitions that add technology, talent, and process expertise in its key growth areas. We’ll now examine how Enpro’s 2026 revenue guidance and acquisition...

If you are wondering whether Performance Food Group's share price still offers value at around US$95.79, you are not alone. Many investors are asking the same question before making their next move. The stock has seen a 2.3% decline over the last 7 days, a 2.0% gain over 30 days, and is up 8.8% year to date, with a 15.6% return over 1 year, 65.2% over 3 years and 70.9% over 5 years. These figures may influence how you think about its risk and reward trade off. Recent company updates and...

In recent weeks, Hershey has been challenged by public claims from a Reese family member that Reese’s ingredients have been cheapened, which the company disputes, while also confronting softer unit sales, higher costs and pressure on operating margins. This clash between brand heritage concerns and evidence of less profitable incremental growth raises questions about how resilient Hershey’s product portfolio and pricing power really are. Next, we’ll examine how this ingredient controversy,...

Allegiant Travel (ALGT) has drawn fresh attention after unveiling Flight #925, a themed Orlando to Knoxville route created with Dollywood Parks & Resorts. The offering pairs air travel with exclusive theme park, entertainment, and lodging perks. See our latest analysis for Allegiant Travel. The latest Flight #925 announcement comes after a stretch of strong momentum in Allegiant Travel’s share price, with a 43% 90 day share price return and 27.06% 1 year total shareholder return, contrasted...

If you are looking at Perrigo and wondering whether the recent share price reflects its true worth, this article will walk you through what the numbers are saying about value. The stock closed at US$14.55, with returns of 0.1% over 7 days, a 1.2% decline over 30 days, 4.8% year to date, and declines of 39.1% over 1 year, 54.5% over 3 years, and 58.8% over 5 years, which can change how investors see both risk and upside potential. Recent news coverage around Perrigo has focused on its...

Recent share performance context for TransDigm Group Recent price moves in TransDigm Group (TDG) have drawn investor attention, with the stock showing mixed returns across different periods and prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for TransDigm Group. The recent pullback, with a 1 month share price return of an 8.67% decline and a year to date share price return of a 4.59% decline from US$1,296.15, contrasts with a 1 year total shareholder...

If you are wondering whether Okta's share price today reflects its true worth, you are not alone. This article will walk through how the current market view compares with several common valuation checks. Okta's share price closed at US$69.51, with returns of 20.3% decline over 7 days, 23.4% decline over 30 days, 16.9% decline year to date, 23.5% decline over 1 year, 3.0% decline over 3 years, and 74.2% decline over 5 years. These moves may have shifted how investors think about its risk and...

In February 2026, Bank of America Corporation completed and announced multiple senior unsecured bond offerings across maturities from 2027 to 2046 totaling several hundred million US dollars, while also unveiling a new Art Consulting service for wealth clients and deepening its data partnership with London Stock Exchange Group. Together with a US$25.00 billion commitment to private-credit deals, these moves highlight Bank of America’s push to broaden fee and interest income sources across...